ISE548 Chap.9 Risk Treatment and Residual Risk
Risk Treatment and Residual Risk
Response verbs with real boundaries
Threats can be avoided, reduced, transferred or accepted; opportunities can be exploited, enhanced, shared or accepted. This chapter explains what each choice changes and what it sacrifices. It treats residual exposure as something that remains owned and monitored after controls, not as an automatic declaration of safety.
Treatment portfolios are assessed against appetite, feasibility and the future evidence that could reopen the choice.
A response is evaluated against the objective, causal pathway and retained consequence. Treatment packages can combine prevention, transfer, contingency and opportunity action, but each layer needs an owner and performance test.
The recommendation should reveal its cost, lost benefit, new dependency and conditions under which the choice must be reopened.
What this chapter covers
- 01
Threat treatment strategies
- 02
Opportunity treatment strategies
- 03
Transfer and retained consequence
- 04
Acceptance and authority
- 05
Risk appetite and escalation
- 06
Residual exposure and monitoring
Worked example · free
Treat both sides of an exhibit loan
- 3Choose threat treatments.
- 2Choose opportunity response.
- 3State residual exposure and evidence.
Key terms
- Risk Avoidance
- Ending or not beginning the activity that creates the exposure.
- Risk Reduction
- Applying controls that lower the likelihood or consequence of an adverse event.
- Risk Transfer
- Allocating specified consequences to a willing third party through contract, insurance or partnership.
- Risk Appetite
- The exposure an organisation is willing to retain while pursuing its objectives.
Risk Treatment and Residual Risk FAQ
Why does insurance not remove the risk?
Insurance can transfer covered financial loss, while operational interruption, reputation, deductibles, exclusions and oversight duties remain. The event still occurs, so prevention and recovery may still be required.
What makes acceptance an informed decision?
The organisation names the exposure, authority, reason, contingency and review trigger after comparing feasible controls. Inaction caused by delay or unclear ownership is not the same as deliberate acceptance.
How do opportunity responses differ from threat responses?
Exploit seeks to make the benefit occur, enhance raises its chance or value, share brings another party's capability and acceptance waits. Applying only threat language can remove the objective the decision was meant to pursue.
What does transfer leave with the organisation?
Insurance or contract terms may move defined financial consequences while operational interruption, reputation, deductibles, exclusions, oversight duties and customer relationships remain. The event itself still occurs unless another control changes it. Read the cover boundary, state the retained loss and identify the internal capability needed to manage the incident.
Transfer is a consequence strategy, not proof that the source disappeared.
When is acceptance an active treatment decision?
Acceptance becomes active when the exposure, evidence, authority, threshold, contingency and review trigger are recorded. The decision should explain why further reduction is disproportionate or infeasible and how the remaining state fits appetite and obligations. Doing nothing because action is expensive is not enough. A named signal must reopen the choice when conditions or control evidence change.
How should a treatment portfolio be tested?
Map each action to the pathway and ask whether layers depend on the same people, supplier, power or information. Verify prevention under demand, review transfer exclusions, rehearse contingency and measure the opportunity outcome. Then inspect interactions: a stronger crate may reduce damage but add handling delay, while a partner may increase reach and create data or governance dependency.
What secondary risks can treatment create?
Outsourcing can concentrate dependency, automation can create common software failure, insurance can create exclusions or moral hazard, and a substitute can introduce new material or interface hazards. Add those pathways to the assessment rather than hiding them inside the claimed reduction. A treatment is credible when both the intended change and the new exposure have owners and review evidence.
How should residual risk be communicated after treatment?
Restate the event and consequence, name the controls that are operating and show the evidence for any changed likelihood or severity. Describe what remains, who accepts it, what contingency is available and which signal reopens the decision. Avoid phrases such as risk addressed or fully transferred. The reader should be able to distinguish implemented prevention, contractual allocation and retained operational exposure.
Exam move
Take one decision with both upside and downside. Write one feasible option under each threat and opportunity strategy, then cross out any option that contradicts the objective. For the remaining portfolio, name the sacrifice, residual exposure, owner and signal that would change the chosen response.
Working through Risk Treatment and Residual Risk in ISE548? Sia is AskSia’s AI Management tutor — ask any ISE548 Risk Treatment and Residual Risk question and get a clear, step-by-step explanation grounded in how ISE548 is taught and assessed. Read this chapter free, then take your hardest questions to Sia.